Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients.
about
Is there a rationale for short cardioplegia re-dosing intervals?Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institutionHistidine and other amino acids in blood and urine after administration of Bretschneider solution (HTK) for cardioplegic arrest in patients: effects on N-metabolism.Custodiol for myocardial protection and preservation: a systematic review.Perfusion techniques for minimally invasive valve procedures.Evidence-based medicine and myocardial protection--where is the evidence?Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass.Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.Mathematical modeling of buffers used in myocardial preservation.The comparison of the effects of Bretschneider's histidine-tryptophan-ketoglutarate and conventional crystalloid cardioplegia on pediatric myocardium at tissue level.
P2860
Q26777859-1A90D722-DD64-43FF-B142-FF116937B01BQ35151632-AB236C17-28ED-4363-A707-F278928BE865Q36908545-29D7B6BC-2D07-4572-95B0-E17FED6A72E1Q36924067-6333FDE5-6487-4C59-8CD3-E01B617575D0Q38172197-28735C33-5F43-47A5-812D-5AB32FF12B84Q38256530-9D1A526B-48A8-41C9-AC12-D0372E49BEC6Q38258296-3F236B1A-A150-4FD9-A8B8-11D7601D8308Q39816946-7C251349-D029-4BA6-B492-8E514A62205AQ41672076-EBBDE412-678D-4D58-AC52-516E95189817Q46641821-4E9A89BD-CF87-4E95-915C-9284F82A948EQ48099984-6B3BCD1D-F0FE-4AD1-A948-2748A090ACAD
P2860
Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Clinical impact of histidine-k ...... n open heart surgery patients.
@en
Clinical impact of histidine-ketoglutarate-tryptophan
@nl
type
label
Clinical impact of histidine-k ...... n open heart surgery patients.
@en
Clinical impact of histidine-ketoglutarate-tryptophan
@nl
prefLabel
Clinical impact of histidine-k ...... n open heart surgery patients.
@en
Clinical impact of histidine-ketoglutarate-tryptophan
@nl
P2093
P1476
Clinical impact of histidine-k ...... n open heart surgery patients.
@en
P2093
P304
P356
10.1016/S0188-4409(01)00296-X
P577
2001-07-01T00:00:00Z